*Clinical Fellow, ∥Professor, Center for Reproductive Sciences, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, San Francisco, California; †Medical Fellow, §Senior Research Advisor, ¶Scientific Communications Consultant, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana; ‡Assistant Professor, Division of Endocrinology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana
Chief Editor’s Note: This article is part of a series of continuing education activities in this Journal through which a total of 36 AMA/PRA Category 1 Credits™ can be earned in 2008. Instructions for how CME credits can be earned appear on the last page of the Table of Contents.
Drs. Draper, Krishnan, and Wong have disclosed that they were/are share stockholders in and were/are employed by Eli Lilly and Company. All other authors have disclosed that they have no financial relationships with or interests in any commercial companies pertaining to this educational activity.
The faculty and staff in a position to control the content of this CME activity have disclosed that they have no financial relationships with, or financial interests in, any commercial companies pertaining to this educational activity.
Lippincott CME Institute, Inc. has identified and resolved all faculty and staff conflicts of interest regarding this educational activity.
Reprint requests to: Robert B. Jaffe, Department of OB/GYN and Reproductive Sciences, University of California—San Francisco, Room HSW 1450, San Francisco CA 94143. E-mail: [email protected].
